In conclusion, we have demonstrated that markers of brain injury are associated with dysregulated immunological responses in COVID-19, and that there may be a separate late process irrespective of initial disease severity which is characterized by elevated serum total tau concentrations and the presence of IgM autoantibodies. Here, MAPT is linked to COVID-19.